Tag: Cancer: Leukemia
Myelodysplastic Syndrome/AML Risk Increased After Chemo
Since 2000, risks for therapy-related myelodysplastic syndrome, AML up after chemo for solid cancers
American Society of Hematology, Dec. 1-4
The 60th American Society of Hematology Annual Meeting and Exposition The annual meeting of the American Society of Hematology was held from Dec....
ASH: Ibrutinib Tops Bendamustine + Rituximab for CLL
Improved progression-free survival with ibrutinib for older adults with untreated CLL
FDA Approves Treatment for AML Patients With Gene Mutation
Expanded approval also granted to mutation assay used to detect FLT3 mutation in AML patients
FDA Approves New Treatment for Acute Myeloid Leukemia
Randomized clinical trial showed significant improvement in overall survival with Daurismo
Duvelisib Promising for Chronic Lymphocytic Leukemia, SLL
Duvelisib extended progression-free survival to 13.3 months versus 9.9 months for ofatumumab
Risk of Relapse Up for Teens, Young Adults With Leukemia
Increased risk of on-therapy relapse, relapse after completing therapy versus children with ALL
FDA Approves Novel Treatment for Hairy Cell Leukemia
Lumoxiti, a CD22-directed cytotoxin, approved for adults who have had at least two prior therapies
FDA Approves Tibsovo for Acute Myeloid Leukemia
Approved for adults with relapsed or refractory acute myeloid leukemia who have IDH1 mutation
Lymphoma, Leukemia Survivors Have Increased Health Care Use
Survivors who are psychologically distressed use even more services than those who aren't
